Literature DB >> 26682919

Renal Cell Carcinomas in Vinylidene Chloride-exposed Male B6C3F1 Mice Are Characterized by Oxidative Stress and TP53 Pathway Dysregulation.

Schantel A Hayes1, Arun R Pandiri2, Thai-vu T Ton3, Hue-Hua L Hong3, Natasha P Clayton3, Keith R Shockley4, Shyamal D Peddada4, Kevin Gerrish5, Michael Wyde6, Robert C Sills3, Mark J Hoenerhoff7.   

Abstract

Vinylidene chloride (VDC) has been widely used in the production of plastics and flame retardants. Exposure of B6C3F1 mice to VDC in the 2-year National Toxicology Program carcinogenicity bioassay resulted in a dose-dependent increases in renal cell hyperplasia, renal cell adenoma, and renal cell carcinomas (RCCs). Among those differentially expressed genes from controls and RCC of VDC-exposed mice, there was an overrepresentation of genes from pathways associated with chronic xenobiotic and oxidative stress as well as c-Myc overexpression and dysregulation of TP53 cell cycle checkpoint and DNA damage repair pathways in RCC. Trend analysis comparing RCC, VDC-exposed kidney, and chamber control kidney showed a conservation of pathway dysregulation in terms of overrepresentation of xenobiotic and oxidative stress, and DNA damage and cell cycle checkpoint pathways in both VDC-exposed kidney and RCC, suggesting that these mechanisms play a role in the pathogenesis of RCC in VDC-exposed mice.
© The Author(s) 2015.

Entities:  

Keywords:  National Toxicology Program; carcinogenicity bioassay; global gene expression; immunohistochemistry; microarray; mutation analysis; quantitative PCR; renal cell carcinoma; renal tubular hyperplasia; vinylidene chloride

Mesh:

Substances:

Year:  2015        PMID: 26682919      PMCID: PMC4752433          DOI: 10.1177/0192623315610820

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  69 in total

Review 1.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

2.  Carcinogenicity bioassays of vinylidene chloride. Research plan and early results.

Authors:  C Maltoni; G Cotti; L Morisi; P Chieco
Journal:  Med Lav       Date:  1977 Jul-Aug       Impact factor: 1.275

Review 3.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

4.  Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations.

Authors:  D Taylor; W M Koch; M Zahurak; K Shah; D Sidransky; W H Westra
Journal:  Hum Pathol       Date:  1999-10       Impact factor: 3.466

5.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

6.  p53 regulation and function in renal cell carcinoma.

Authors:  Hazel E Warburton; Mark Brady; Nikolina Vlatković; W Marston Linehan; Keith Parsons; Mark T Boyd
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

7.  Mutagenicity of vinyl chloride, vinylidene chloride and chloroprene in V79 Chinese hamster cells.

Authors:  C Drevon; T Kuroki
Journal:  Mutat Res       Date:  1979-06       Impact factor: 2.433

8.  Genetic activity of vinylidene chloride in yeast.

Authors:  G Bronzetti; C Bauer; C Corsi; C Leporini; R Nieri; R del Carratore
Journal:  Mutat Res       Date:  1981-06       Impact factor: 2.433

9.  Carcinogenicity studies on vinylidene chloride.

Authors:  P L Viola; A Caputo
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

10.  Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice.

Authors:  Joachim Albers; Michal Rajski; Désirée Schönenberger; Sabine Harlander; Peter Schraml; Adriana von Teichman; Strahil Georgiev; Peter J Wild; Holger Moch; Wilhelm Krek; Ian J Frew
Journal:  EMBO Mol Med       Date:  2013-04-22       Impact factor: 12.137

View more
  1 in total

1.  The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.

Authors:  Jin-Shu Pang; Zhe-Kun Li; Peng Lin; Xiao-Dong Wang; Gang Chen; Hai-Biao Yan; Sheng-Hua Li
Journal:  Oncol Rep       Date:  2019-02-14       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.